Separation of yttrium-90 and strontium-90 on papers impregnated with ionizable crown ethers

1990 ◽  
Vol 62 (21) ◽  
pp. 2412-2414 ◽  
Author(s):  
Chien M. Wai ◽  
H. S. Du
Keyword(s):  
Crown Ethers ◽  
Strontium 90 ◽  
Yttrium 90

Separation of yttrium-90 from strontium-90 by solvent extraction with ionizable crown ethers

1993 ◽  
Vol 65 (10) ◽  
pp. 1350-1354 ◽  
Author(s):  
Donald J. Wood ◽  
S. Elshani ◽  
H. S. Du ◽  
N. R. Natale ◽  
C. M. Wai
Keyword(s):  
Solvent Extraction ◽  
Crown Ethers ◽  
Strontium 90 ◽  
Yttrium 90

Strahlenbehandlung von Hautkrankheiten mit Strontium 90/Yttrium 90

1960 ◽  
Vol 211-211 (1) ◽  
pp. 389-392 ◽  
Author(s):  
W. Sevin ◽  
R. Anger
Keyword(s):  
Strontium 90 ◽  
Yttrium 90

Direct Absorption of Dissolved Strontium-90 and Yttrium-90 by Tadpoles of Rana temporaria

Nature ◽  
1958 ◽  
Vol 182 (4644) ◽  
pp. 1242-1243 ◽  
Author(s):  
J. W. LUCAS ◽  
D. C. PICKERING
Keyword(s):  
Rana Temporaria ◽  
Direct Absorption ◽  
Strontium 90 ◽  
Yttrium 90

scholarly journals AN UPDATE ON TOXICITY OF THERAPEUTIC RADIONUCLIDES

2021 ◽  
Vol 9 (4) ◽  
Author(s):  
Dilip Vallathol ◽  
Raghunadharao Digumarti
Keyword(s):  
Side Effects ◽  
Short Term ◽  
Targeted Radiotherapy ◽  
Myeloid Neoplasms ◽  
Strontium 90 ◽  
Gonadal Toxicity ◽  
Iodine 131 ◽  
The Many ◽  
Yttrium 90

Targeted radiotherapy is an evolving and promising modality of cancer treatment. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the possibility of assessing the uptake by the tumor prior to the therapy. A number of radionuclides, such as iodine-131 (131I), phosphorus-32 (32P), strontium-90 (90Sr), and yttrium-90 (90Y), have been used successfully for the treatment of many benign and malignant disorders. The toxicity to radionuclides has come into vogue with its increasing utilization for multiple indications. Short term hematological toxicities include cytopenias and long term hematological toxicities include myeloid neoplasms. Non hematological toxicities commonly include renal and hepatotoxicity and long term toxicities like gonadal toxicity. This review focuses on the toxicities which need to be monitored during use of therapeutic radionuclides.

scholarly journals Separation of Strontium-90 and Yttrium-90 by the Thin-layer Chromatographic Method

RADIOISOTOPES ◽  
1964 ◽  
Vol 13 (5) ◽  
pp. 377-381 ◽  
Author(s):  
Hiroshi HAMAGUCHI ◽  
Nagao IKEDA ◽  
Aiko IWASA
Keyword(s):  
Thin Layer ◽  
Chromatographic Method ◽  
Strontium 90 ◽  
Yttrium 90
Sign in / Sign up

Export Citation Format

Share Document